Dexamethasone implants appear to be the best treatment for persistent or recurrent macular edema that often occurs in patients with uveitis, findings from a new study show. The 12-week, multicenter, ...
Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a ...
ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, Inc., a clinical-stage biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced ...
Ophthalmologists in the US will soon have more options in their toolkit to manage neovascular age-related macular degeneration (AMD) and macular edema associated with uveitis. Susvimo, a 100 mg/mL ...
ANI Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved an expanded label for ILUVIEN, a fluocinolone acetonide intravitreal implant, allowing it to be used ...
Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a ...
Uveitis is a complex and potentially sight-threatening eye condition that encompasses a range of inflammatory disorders affecting the uvea, the middle layer of the eye. When it comes to diagnosis and ...
Intravitreal ceftazidime may help treat syphilitic uveitis when IV penicillin is delayed. Ceftazidime is not a substitute for IV penicillin, which is the preferred treatment. A case series reported ...
Patients Treated in the Clinical Trial Exhibited Improvement in Best Corrected Visual Acuity No Meaningful Increases in IOP Observed; No Patient Required IOP-lowering Medication Clearside Biomedical, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results